Investor List:

Top Pharmaceuticals Series A Investors in Washington, D.C. (48)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Pharmaceuticals investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Ali Behbahani, General Partner at New Enterprise Associates (NEA)
Ali Behbahani
Sweet spot: $25.0M
Range: $2.0M - $50.0M
Investors in Washington (DC)
Photo of Ed Mathers, Partner at New Enterprise Associates (NEA)
Ed Mathers
Sweet spot: $25.0M
Range: $2.0M - $50.0M
Investors in Maryland, Investors in Washington (DC)
Photo of Kavita Patel, Venture Partner at New Enterprise Associates (NEA)
Kavita Patel
Sweet spot: $25.0M
Range: $2.0M - $50.0M
Investors in Washington (DC)
Photo of Sara Nayeem, Partner at Avoro Ventures
Sara Nayeem
Sweet spot: $1M
Range: $100K - $10.0M
Investors in New York City, Investors in Washington (DC)
Photo of Amy Kruse, General Partner at Prime Movers Lab
Amy Kruse
Prime Movers Lab·General Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Washington (D.C.)
Investors in AgTech (Series A), Investors in Pharmaceuticals (Seed), Investors in AgTech (Seed), Investors in BioTech (Seed), Investors in AgTech (Seed), Investors in BioTech (Series A), Investors in AI (Seed), Investors in Pharmaceuticals (Series A), Investors in AI (Seed), Investors in BioTech (Seed), Investors in AI (Series A), Investors in Enterprise (Seed), Investors in Enterprise (Series A), Investors in Pharmaceuticals (Seed), Investors in AgTech (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in Enterprise (Series A), Investors in Pharmaceuticals (Series A), Investors in Washington, D.C. (Other Lists), Investors in Enterprise (Seed)
Photo of Harry Glorikian, General Partner at New Ventures Funds
Harry Glorikian
New Ventures Funds·General Partner
Sweet spot: $0
Range: $0 - $0
Investors in United States, Investors in Virginia Beach (VA), Investors in Boston (MA)
Photo of Paul Clark, Managing Director at VentureSouth
Paul Clark
VentureSouth·Managing Director
Sweet spot: $10K
Range: $5K - $20K
Investors in Greenville (SC), Investors in Richmond (VA)
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in Space (Series A), Investors in Space (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Enterprise (Seed), Investors in Enterprise (Series A), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in SaaS (Seed), Investors in Pharmaceuticals (Seed), Investors in Space (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Enterprise (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in SaaS (Series A), Investors in Space (Series A), Investors in Pharmaceuticals (Series A), Investors in Washington, D.C. (Other Lists), Investors in Enterprise Applications (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Enterprise Applications (Seed), Investors in Enterprise Applications (Series A), Investors in Enterprise Applications (Seed), Investors in SaaS (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in SaaS (Seed), Investors in Enterprise (Seed)
Photo of Tom V. Brooks, General Partner at Catalio Capital
Tom V. Brooks
Catalio Capital·General Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Denver (CO), Investors in Baltimore (MD)
Investors in Pharmaceuticals (Seed), Investors in EnergyTech (Seed), Investors in EnergyTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in EnergyTech (Seed), Investors in EnergyTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in EnergyTech (Series A), Investors in EnergyTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Washington, D.C. (Other Lists), Investors in Colorado / Utah (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed)